{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T23:37:49Z","timestamp":1776123469548,"version":"3.50.1"},"reference-count":63,"publisher":"Georg Thieme Verlag KG","issue":"07","funder":[{"name":"CONICET, Fundaci\u00f3n Rene Bar\u00f3n, and Academia Nacional de Medicina"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Thromb Hemost"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Type 2A and 2M von Willebrand disease (VWD) broadly show similar phenotypic parameters, but involve different pathophysiological mechanisms. This report presents the clinical and laboratory profiles of type 2A and type 2M patients genotypically diagnosed at one large center. Higher bleeding score values and a higher incidence of major bleeding episodes were observed in type 2A compared with type 2M, potentially reflective of the absence of large and intermediate von Willebrand factor (VWF) multimers in 2A. In type 2A, most of disease-causing variants (DCVs) appeared to be responsible for increased VWF clearance and DCV clustered in the VWF-A1 domain resulted in more severe clinical profiles. In type 2M, DCV in the VWF-A1 domain showed different laboratory patterns, related to either reduced synthesis or shortened VWF survival, and DCV in the VWF-A2 domain showed patterns related mainly to shortened survival. VWF-type 1 collagen binding\/Ag (C1B\/Ag) showed different patterns according to DCV location: in type 2A VWD, C1B\/Ag was much lower when DCVs were located in the VWF-A2 domain. In type 2M with DCV in the VWF-A1domain, C1B\/Ag was normal, but with DCV in the VWF-A2 domain, C1B\/Ag was low. The higher frequency of major bleeding in VWD 2M patients with DCV in the VWF-A2 domain than that with DCV in the VWF-A1 domain could be a summative effect of abnormal C1B\/Ag, on top of the reduced VWF-GPIb binding. In silico modeling suggests that DCV impairing the VWF-A2 domain somehow modulates collagen binding to the VWF-A3 domain. Concomitant normal FVIII:C\/Ag and VWFpp\/Ag, mainly in type 2M VWD, suggest that other nonidentified pathophysiological mechanisms, neither related to synthesis\/retention nor survival of VWF, would be responsible for the presenting phenotype.<\/jats:p>","DOI":"10.1055\/s-0041-1726097","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T22:42:07Z","timestamp":1623796927000},"page":"862-874","source":"Crossref","is-referenced-by-count":12,"title":["Type 2A and 2M von Willebrand Disease: Differences in Phenotypic Parameters According to the Affected Domain by Disease-Causing Variants and Assessment of Pathophysiological Mechanisms"],"prefix":"10.1055","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4077-1796","authenticated-orcid":false,"given":"Adriana In\u00e9s","family":"Woods","sequence":"additional","affiliation":[{"name":"Laboratorio de Hemostasia y Trombosis, IMEX-CONICET-Academia Nacional de Medicina de Buenos Aires. CABA, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2083-1269","authenticated-orcid":false,"given":"Juvenal","family":"Paiva","sequence":"additional","affiliation":[{"name":"Departamento de Hemostasia y Trombosis, Instituto de Investigaciones Hematol\u00f3gicas, Academia Nacional de Medicina de Buenos Aires. CABA, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7370-1073","authenticated-orcid":false,"given":"D\u00e9bora Marina","family":"Primrose","sequence":"additional","affiliation":[{"name":"Qu\u00edmica de los Alimentos, Facultad de Agronom\u00eda y Ciencias Agroalimentarias, Universidad de Mor\u00f3n. Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6933-1057","authenticated-orcid":false,"given":"Alicia Noem\u00ed","family":"Blanco","sequence":"additional","affiliation":[{"name":"Departamento de Hemostasia y Trombosis, Instituto de Investigaciones Hematol\u00f3gicas, Academia Nacional de Medicina de Buenos Aires. CABA, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2971-9217","authenticated-orcid":false,"given":"Anal\u00eda","family":"S\u00e1nchez-Luceros","sequence":"additional","affiliation":[{"name":"Laboratorio de Hemostasia y Trombosis, IMEX-CONICET-Academia Nacional de Medicina de Buenos Aires. CABA, Argentina"},{"name":"Departamento de Hemostasia y Trombosis, Instituto de Investigaciones Hematol\u00f3gicas, Academia Nacional de Medicina de Buenos Aires. CABA, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2021,6,15]]},"reference":[{"issue":"10","key":"ref1","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"J E Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"03","key":"ref2","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1111\/hae.12903","article-title":"Type 2M von Willebrand disease - more often misidentified than correctly identified","volume":"22","author":"E J Favaloro","year":"2016","journal-title":"Haemophilia"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.21037\/aob.2017.12.04","article-title":"Diagnosis of von Willebrand disease in Argentina: a single institution experience","volume":"2","author":"A I Woods","year":"2017","journal-title":"Ann Blood"},{"issue":"08","key":"ref4","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1177\/1076029616675969","article-title":"von Willebrand disease: a concise review and update for the practicing physician","volume":"23","author":"A Swami","year":"2017","journal-title":"Clin Appl Thromb Hemost"},{"issue":"03","key":"ref5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/hae.13957","article-title":"Comparative assessment of von Willebrand factor multimers vs activity for von Willebrand disease using modern contemporary methodologies","volume":"26","author":"E J Favaloro","year":"2020","journal-title":"Haemophilia"},{"issue":"04","key":"ref6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/bjh.13064","article-title":"The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology","volume":"167","author":"M A Laffan","year":"2014","journal-title":"Br J Haematol"},{"issue":"S 01","key":"ref7","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.thromres.2007.03.014","article-title":"Von Willebrand disease - phenotype versus genotype: deficiency versus disease","volume":"120","author":"D Lillicrap","year":"2007","journal-title":"Thromb Res"},{"issue":"S 04","key":"ref8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/hae.13475","article-title":"Fifth \u00c5land Island conference on von Willebrand disease","volume":"24","author":"E Berntorp","year":"2018","journal-title":"Haemophilia"},{"issue":"02","key":"ref9","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/hae.13175","article-title":"Molecular diagnosis of von Willebrand disease","volume":"23","author":"L Baronciani","year":"2017","journal-title":"Haemophilia"},{"issue":"04","key":"ref10","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1055\/s-0039-3402430","article-title":"Genetic background of von Willebrand disease: history, current state, and future perspectives","volume":"46","author":"J Zolkova","year":"2020","journal-title":"Semin Thromb Hemost"},{"issue":"05","key":"ref11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1055\/s-0036-1579641","article-title":"Type 2M and type 2A von Willebrand disease: similar but different","volume":"42","author":"E J Favaloro","year":"2016","journal-title":"Semin Thromb Hemost"},{"issue":"08","key":"ref12","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/jth.13742","article-title":"Clinical and laboratory phenotype variability in type 2M von Willebrand disease","volume":"15","author":"A L Doruelo","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"02","key":"ref13","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1111\/hae.13156","article-title":"VWF collagen (types III and VI)-binding defects in a cohort of type 2M VWD patients - a strategy for improvement of a challenging diagnosis","volume":"23","author":"T Fidalgo","year":"2017","journal-title":"Haemophilia"},{"issue":"08","key":"ref14","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1074\/jbc.M115.703850","article-title":"Mutational constraints on local unfolding inhibit the rheological adaptation of von Willebrand factor","volume":"291","author":"A Tischer","year":"2016","journal-title":"J Biol Chem"},{"issue":"01","key":"ref15","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1111\/j.1365-2516.2011.02676.x","article-title":"A family with type 2M VWD with normal VWF:RCo but reduced VWF:CB and a M1761K mutation in the A3 domain","volume":"18","author":"D Keeling","year":"2012","journal-title":"Haemophilia"},{"issue":"06","key":"ref16","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1538-7836.2010.03869.x","article-title":"Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWD","volume":"8","author":"V H Flood","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"12","key":"ref17","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1182\/blood-2012-09-455089","article-title":"VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease","volume":"121","author":"J Eikenboom","year":"2013","journal-title":"Blood"},{"issue":"19","key":"ref18","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1182\/blood-2014-09-603241","article-title":"von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease","volume":"125","author":"Y V Sanders","year":"2015","journal-title":"Blood"},{"issue":"02","key":"ref19","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1055\/s-0037-1612981","article-title":"The factor VIII\/von Willebrand factor ratio discriminates between reduced synthesis and increased clearance of von Willebrand factor","volume":"87","author":"J C Eikenboom","year":"2002","journal-title":"Thromb Haemost"},{"issue":"08","key":"ref21","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/j.1538-7836.2009.03499.x","article-title":"Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire","volume":"7","author":"M Bowman","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"06","key":"ref22","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0029-7844(95)00062-V","article-title":"A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss","volume":"85","author":"C A Janssen","year":"1995","journal-title":"Obstet Gynecol"},{"issue":"04","key":"ref23","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"S Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-1-4939-7196-1_20","article-title":"One-stage factor VIII assays","volume":"1646","author":"E Duncan","year":"2017","journal-title":"Methods Mol Biol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/978-1-4939-7196-1_30","article-title":"Laboratory testing for von Willebrand factor antigen (VWF:Ag)","volume":"1646","author":"E J Favaloro","year":"2017","journal-title":"Methods Mol Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/978-1-4939-7196-1_32","article-title":"Laboratory testing for von Willebrand factor ristocetin cofactor (VWF:RCo)","volume":"1646","author":"S Mohammed","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"01","key":"ref27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-0038-1660481","article-title":"Evaluation of the utility of von Willebrand factor propeptide in the differential diagnosis of von Willebrand disease and acquired von Willebrand syndrome","volume":"45","author":"F Stufano","year":"2019","journal-title":"Semin Thromb Hemost"},{"issue":"05","key":"ref28","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0049-3848(89)90206-5","article-title":"Visualization of the multimeric structure of von Willebrand factor by immunoenzymatic stain using avidin-peroxidase complex instead of avidin-biotin peroxidase complex","volume":"53","author":"C Farias","year":"1989","journal-title":"Thromb Res"},{"issue":"01","key":"ref29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2516.2011.02569.x","article-title":"C1272F: a novel type 2A von Willebrand's disease mutation in A1 domain; its clinical significance","volume":"18","author":"A I Woods","year":"2012","journal-title":"Haemophilia"},{"issue":"15","key":"ref30","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1002\/elps.1150181505","article-title":"SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling","volume":"18","author":"N Guex","year":"1997","journal-title":"Electrophoresis"},{"issue":"02","key":"ref31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nprot.2016.169","article-title":"The ClusPro web server for protein-protein docking","volume":"12","author":"D Kozakov","year":"2017","journal-title":"Nat Protoc"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"W363-7","DOI":"10.1093\/nar\/gki481","article-title":"PatchDock and SymmDock: servers for rigid and symmetric docking","volume":"33","author":"D Schneidman-Duhovny","year":"2005","journal-title":"Nucleic Acids Res"},{"issue":"01","key":"ref33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/pro.3289","article-title":"PDBsum: structural summaries of PDB entries","volume":"27","author":"R A Laskowski","year":"2018","journal-title":"Protein Sci"},{"issue":"13","key":"ref34","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"E F Pettersen","year":"2004","journal-title":"J Comput Chem"},{"key":"ref35","first-page":"119","article-title":"Approximate is better than \u2018exact\u2019 for interval estimation of binomial proportions","volume":"52","author":"A Agresti","year":"1998","journal-title":"Am Stat"},{"issue":"01","key":"ref36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1160\/TH12-07-0475","article-title":"Characterisation of mutations and molecular studies of type 2 von Willebrand disease","volume":"109","author":"F Ahmad","year":"2013","journal-title":"Thromb Haemost"},{"issue":"05","key":"ref37","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/bjh.15709","article-title":"Characterization of VWF gene conversions causing von Willebrand disease","volume":"184","author":"F Ahmad","year":"2019","journal-title":"Br J Haematol"},{"issue":"05","key":"ref38","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1055\/s-0031-1281037","article-title":"Management of inherited von Willebrand disease in Italy: results from the retrospective study on 1234 patients","volume":"37","author":"A B Federici","year":"2011","journal-title":"Semin Thromb Hemost"},{"issue":"05","key":"ref39","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1177\/1076029612441054","article-title":"A common VWF exon 28 haplotype in the Turkish population","volume":"19","author":"E Berber","year":"2013","journal-title":"Clin Appl Thromb Hemost"},{"issue":"23","key":"ref40","doi-asserted-by":"crossref","first-page":"9226","DOI":"10.1073\/pnas.0903679106","article-title":"Structural specializations of A2, a force-sensing domain in the ultralarge vascular protein von Willebrand factor","volume":"106","author":"Q Zhang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"28","key":"ref41","doi-asserted-by":"crossref","first-page":"11602","DOI":"10.1073\/pnas.1018559108","article-title":"Mechanism of von Willebrand factor scissile bond cleavage by a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13)","volume":"108","author":"Y Xiang","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"05","key":"ref42","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2008-04-148759","article-title":"Extensive contacts between ADAMTS13 exosites and von Willebrand factor domain A2 contribute to substrate specificity","volume":"112","author":"W Gao","year":"2008","journal-title":"Blood"},{"issue":"04","key":"ref43","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/hae.12117","article-title":"Variability in platelet- and collagen-binding defects in type 2M von Willebrand disease","volume":"19","author":"D M Larsen","year":"2013","journal-title":"Haemophilia"},{"issue":"04","key":"ref44","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2012.04661.x","article-title":"Different bleeding risk in type 2A and 2M von Willebrand disease: a 2-year prospective study in 107 patients","volume":"10","author":"G Castaman","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"09","key":"ref45","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/j.1538-7836.2007.02666.x","article-title":"Challenges in defining type 2M von Willebrand disease: results from a Canadian cohort study","volume":"5","author":"P D James","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"04","key":"ref46","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1055\/s-0037-1613060","article-title":"Identification of a new type 2M von Willebrand disease mutation also at position 1324 of von Willebrand factor","volume":"87","author":"L Hilbert","year":"2002","journal-title":"Thromb Haemost"},{"issue":"06","key":"ref47","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/jth.12927","article-title":"CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease","volume":"13","author":"Y V Sanders","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"08","key":"ref48","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1055\/s-2007-1000364","article-title":"An update on the von Willebrand factor collagen binding assay: 21 years of age and beyond adolescence but not yet a mature adult","volume":"33","author":"E J Favaloro","year":"2007","journal-title":"Semin Thromb Hemost"},{"issue":"06","key":"ref49","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1538-7836.2012.04729.x","article-title":"Differential sensitivity of von Willebrand factor (VWF) \u2018activity\u2019 assays to large and small VWF molecular weight forms: a cross-laboratory study comparing ristocetin cofactor, collagen-binding and mAb-based assays","volume":"10","author":"E J Favaloro","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"30","key":"ref50","doi-asserted-by":"crossref","first-page":"22831","DOI":"10.1074\/jbc.M110.103358","article-title":"Destabilization of the A1 domain in von Willebrand factor dissociates the A1A2A3 tri-domain and provokes spontaneous binding to glycoprotein Ibalpha and platelet activation under shear stress","volume":"285","author":"M Auton","year":"2010","journal-title":"J Biol Chem"},{"issue":"29","key":"ref51","doi-asserted-by":"crossref","first-page":"10578","DOI":"10.1073\/pnas.0402041101","article-title":"Binding of platelet glycoprotein Ibalpha to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13","volume":"101","author":"K Nishio","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"05","key":"ref52","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1055\/s-0038-1656094","article-title":"von Willebrand factor without the A2 domain is resistant to proteolysis","volume":"77","author":"H Lankhof","year":"1997","journal-title":"Thromb Haemost"},{"issue":"07","key":"ref53","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/j.1538-7836.2007.02536.x","article-title":"Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibalpha","volume":"5","author":"C Martin","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"02","key":"ref54","doi-asserted-by":"crossref","first-page":"eaaq1477","DOI":"10.1126\/sciadv.aaq1477","article-title":"Autoregulation of von Willebrand factor function by a disulfide bond switch","volume":"4","author":"D Butera","year":"2018","journal-title":"Sci Adv"},{"issue":"06","key":"ref55","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1055\/s-0037-1614163","article-title":"Binding of von Willebrand factor to collagen type III: role of specific amino acids in the collagen binding domain of vWF and effects of neighboring domains","volume":"84","author":"R M van der Plas","year":"2000","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref56","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00894-004-0194-9","article-title":"Molecular modeling of the von Willebrand factor A2 domain and the effects of associated type 2A von Willebrand disease mutations","volume":"10","author":"J J Sutherland","year":"2004","journal-title":"J Mol Model"},{"issue":"03","key":"ref57","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1365-2516.2008.01703.x","article-title":"L1503R is a member of group I mutation and has dominant-negative effect on secretion of full-length VWF multimers: an analysis of two patients with type 2A von Willebrand disease","volume":"14","author":"T Kashiwagi","year":"2008","journal-title":"Haemophilia"},{"issue":"06","key":"ref58","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1182\/blood-2005-04-1758","article-title":"Impact of mutations in the von Willebrand factor A2 domain on ADAMTS13-dependent proteolysis","volume":"107","author":"W A Hassenpflug","year":"2006","journal-title":"Blood"},{"issue":"19","key":"ref59","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1182\/blood-2011-06-360875","article-title":"Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storage","volume":"119","author":"P M Jacobi","year":"2012","journal-title":"Blood"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000214856","article-title":"Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management","volume":"121","author":"J J Michiels","year":"2009","journal-title":"Acta Haematol"},{"issue":"11","key":"ref61","doi-asserted-by":"crossref","first-page":"e0188405","DOI":"10.1371\/journal.pone.0188405","article-title":"A common mechanism by which type 2A von Willebrand disease mutations enhance ADAMTS13 proteolysis revealed with a von Willebrand factor A2 domain FRET construct","volume":"12","author":"C J Lynch","year":"2017","journal-title":"PLoS One"},{"issue":"06","key":"ref62","doi-asserted-by":"crossref","first-page":"e502","DOI":"10.1111\/hae.13084","article-title":"von Willebrand disease type 1 mutation p.Arg1379Cys and the variant p.Ala1377Val synergistically determine a 2M phenotype in four Italian patients","volume":"22","author":"M T Pagliari","year":"2016","journal-title":"Haemophilia"},{"issue":"01","key":"ref63","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/rth2.12067","article-title":"Combined effects of two mutations in von Willebrand disease 2M phenotype","volume":"2","author":"A I Woods","year":"2017","journal-title":"Res Pract Thromb Haemost"},{"issue":"02","key":"ref64","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1111\/hae.13401","article-title":"Discordant von Willebrand factor (VWF) activity in patients with VWF p.Gly1324Ser confirmed in vitro","volume":"24","author":"M Bowman","year":"2018","journal-title":"Haemophilia"}],"container-title":["Seminars in Thrombosis and Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1726097.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:58:20Z","timestamp":1633395500000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0041-1726097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,15]]},"references-count":63,"journal-issue":{"issue":"07","published-online":{"date-parts":[[2021,10,4]]},"published-print":{"date-parts":[[2021,10]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1726097","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0094-6176","1098-9064"],"issn-type":[{"value":"0094-6176","type":"print"},{"value":"1098-9064","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,15]]}}}